Acorda Therapeutics’ official committee of unsecured creditors formed

By Sarah Lizee

Olympia, Wash., April 15 – Acorda Therapeutics, Inc.’s official committee of unsecured creditors was appointed on Monday, according to a notice filed with the U.S. Bankruptcy Court for the Southern District of New York.

The members are Prime Vigilance Ltd., based in Guildford, U.K.; Research Catalyst, LLC, based in Highlands Ranch, Colo.; and Catalent Massachusetts LLC, based in Somerset, N.J.

Pearl River, N.Y.-based Acorda Therapeutics develops therapies to restore function and improve the lives of people with neurological disorders. The company filed bankruptcy on April 1 under Chapter 11 case number 24-22284.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.